blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0476935

EP0476935 - New indol and indoline derivatives [Right-click to bookmark this link]
Former [1992/13]Pharmaceutical compounds
[1995/30]
StatusNo opposition filed within time limit
Status updated on  31.05.1996
Database last updated on 03.10.2024
Most recent event   Tooltip31.05.1996No opposition filed within time limitpublished on 17.07.1996 [1996/29]
Applicant(s)For all designated states
Lilly Industries Limited
Kingsclere Road Basingstoke
Hants RG21 2XA / GB
[N/P]
Former [1992/13]For all designated states
LILLY INDUSTRIES LIMITED
Kingsclere Road
Basingstoke Hants RG21 2XA / GB
Inventor(s)01 / Gilmore, Jeremy
31 Danebury Walk
Paddock Hill, Frimley, Surrey / GB
[1992/13]
Representative(s)Hudson, Christopher Mark, et al
Lilly Industries Limited European Patent Operations Erl Wood Manor Windlesham
Surrey GU20 6PH / GB
[N/P]
Former [1992/13]Hudson, Christopher Mark, et al
Lilly Industries Limited European Patent Operations Erl Wood Manor
Windlesham Surrey GU20 6PH / GB
Application number, filing date91308365.512.09.1991
[1992/13]
Priority number, dateGB1990002033818.09.1990         Original published format: GB 9020338
[1992/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0476935
Date:25.03.1992
Language:EN
[1992/13]
Type: B1 Patent specification 
No.:EP0476935
Date:26.07.1995
Language:EN
[1995/30]
Search report(s)(Supplementary) European search report - dispatched on:EP09.12.1991
ClassificationIPC:C07D209/08, A61K31/40
[1992/13]
CPC:
C07D209/08 (EP,US); A61P11/00 (EP); A61P13/12 (EP);
A61P17/00 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P7/10 (EP); A61P9/00 (EP); A61P9/08 (EP);
A61P9/10 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   NL,   SE [1992/13]
TitleGerman:Neue Indol- und Indolin-Verbindungen[1992/13]
English:New indol and indoline derivatives[1995/30]
French:Nouveaux composés indoliques ou indoliniques[1992/13]
Former [1992/13]Pharmaceutical compounds
Examination procedure23.09.1991Examination requested  [1992/13]
21.12.1994Despatch of communication of intention to grant (Approval: Yes)
20.01.1995Communication of intention to grant the patent
18.03.1995Fee for grant paid
18.03.1995Fee for publishing/printing paid
Opposition(s)27.04.1996No opposition filed within time limit [1996/29]
Fees paidRenewal fee
11.10.1993Renewal fee patent year 03
11.11.1994Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.09.199303   M06   Fee paid on   11.10.1993
30.09.199404   M06   Fee paid on   11.11.1994
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP0159376  (HOECHST ROUSSEL PHARMA [US]);
 [A]EP0242167  (ICI AMERICA INC [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.